NASDAQ:ACST

Acasti Pharma Inc Earning Date

USA |NASDAQ |USD |ADR

ACST Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 15, 2021 Sep 2021 - $-0.02 $-0.48
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 15, 2021 Sep 2021 - $115.00K $0.00

Acasti Pharma Inc's next earnings date is Monday, Nov 15, 2021 for the fiscal quarter ending Sep 2021.

ACST Earnings Date & History Chart

ACST Earnings & Revenue Forecast

ACST Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Mar 2022 0 $0.00 $0.00 $0.00

ACST Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Mar 2022 0 / 1 $0.44 $0.44 $0.44

ACST Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Mar 2022 2 $62.33M $16.30M $108.36M

ACST Earnings Date & Revenue History

ACST Earnings History

|
Show More
Show More

ACST Revenue History

|
Show More
Show More

Acasti Pharma Inc Next Earnings Date & Report

ACST Next Earnings Date & Report Preview: Sep 2021 (FQ)

ACST's next earnings date is Monday, Nov 15, 2021 for the fiscal quarter ending Sep 30, 2021.

Acasti Pharma Inc Previous Earnings Dates & Reports

ACST Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Acasti Pharma Inc's previous earnings date was Aug 12, 2021 for its fiscal quarter ended Jun 30, 2021.

ACST's earnings per share (EPS) was $-0.02.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -50.00%, and higher than the same period a year before (Jun 2020) by -96.25%.

Revenues were $115.00K.

The company reported a net income of $-3.12M.

Free cash flow for the quarter was $-3.40M , compared to $-1.76M last quarter and $-4.34M a year before.

ACST ended the quarter with $66.00K in total debt, a decrease of -23.26% compared to the previous quarter.